BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Yan et al. applied FPCA to longitudinal measurements of BCR-ABL gene expression levels to extract features, and use these features as covariates in a Cox proportional hazard model to conduct dynamic predictions of chronic myeloid leukemia [23].